Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer: Experience from four nonrandomized studies

Strahlentherapie und Onkologie

Volumn 179, Issue 6, 2003, Pages 390-395

  Bieri, Sabine ^a   Bentzen, Soeren M ^b   Huguenin, Pia ^c   Allal, Abdelkarim S ^d   Cozzi, Luca ^e   Landmann, Christine ^f   Monney, May ^g   Bernier, Jacques ^e  

^a Hopital de Sion   (Switzerland)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adverse effects; Chemotherapy; Head and neck cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DEATH; DYSPHAGIA; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; WEIGHT REDUCTION;

EID: 0038317889     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1077-1     Document Type: Article

References (21)

1. Allal AS, Bieri S, Miralbell R, et al. Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone. Ann Oncol 1997;8:681-4.
2. Allal AS, Miralbell R, Pipard G, et al. Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma. Acta Oncol 1997;36:267-71.
3. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-7.
4. Baumann M, Klages HT. Comparison of various fractionation schedules in curative radiotherapy alone of locally advanced head and neck tumors. Strahlenther Onkol 2001;177:162-5.
5. Bentzen SM. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 1998;46:5-18.
6. Bentzen SM, Overgaard J. Clinical normal-tissue radiobiology. In: Tobias JS, Thomas PRM, eds. Current radiation oncology. London: Arnold, 1996:37-67.
7. Bentzen SM, Saunders MI, Dische S, et al. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 2001;60:123-35.
8. Brizel, DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
9. Coppin C. The description of chemotherapy delivery: options and pitfalls. Semin Oncol 1987;14:34-42.
10. Dobrowsky W, Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers (1). Radiother Oncol 2000;57:119-24.
11. Glicksman AS, Wanebo HJ, Slotman G, et al. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997;39:721-9.
12. Harari PM. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol 1997;15:2050-5.
13. Huguenin P, Glanzmann C, Taussky D, et al. Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Long-term results including functional outcome. Strahlenther Onkol 1998;174:397-402.
14. Leyvraz S, Pasche P, Bauer J, et al. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. J Clin Oncol 1994;12:1876-85.
15. Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996;40:137-45.
16. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992;327:1115-21.
17. Peters LJ, Ang KK, Thames HD. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 1988;27:185-94.
18. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. NACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
19. Tobias JS. Chemotherapy-radiotherapy combinations for advanced head and neck cancer. In: Tobias JS, Thomas PRM, eds. Current radiation oncology, vol 1. London: Arnold: 1994:231-49.
20. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:1-12.
21. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-24.